NCT06291077View on ClinicalTrials.gov

Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO>

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions

Kidney Diseases

Interventions

DRUG

Belatacept

Changing of anticalcineurins by Belatacept

DRUG

anticalcineurins

Keeping of anticalcineurins

All Listed Sponsors

lead

University Hospital, Rouen

OTHER